Rare diseases often exist in the shadows of mainstream healthcare, affecting millions worldwide with their unique challenges. At JMIR Publications, we believe in the power of knowledge to illuminate these dark corners and provide hope and support to those affected. Through our commitment to open access publishing, we strive to bring cutting-edge research and insights to the forefront, shedding light on rare diseases and paving the way for improved understanding and treatment. 

Join Gunther Eysenbach, the founder, CEO, and executive editor of JMIR Publications, as he reflects on the company's 25th anniversary and its pioneering journey in the scholarly publishing industry.

Every year, on February 15th, the world comes together to observe International Childhood Cancer Day. This day serves as a poignant reminder of the ongoing battle against pediatric cancer and the collective efforts needed to improve outcomes for young patients and their families. As we reflect on the significance of this day, it's crucial to recognize the strides made in cancer research and treatment, particularly through innovative technologies and patient-centered approaches.

JMIR Publications Presents an International Women’s Day Webinar titled: Breaking Barriers: Inspiring Inclusion for Women in Medicine and eHealth. Join us for an inspiring and thought-provoking exploration of the achievements and challenges faced by women in medicine and eHealth.

(Toronto, January, 22, 2024) 2024 will mark the 25th anniversary for JMIR Publications, the leading open access digital health research publisher. Founded in 1999 by Gunther Eysenbach, MD, MPH, FACMI,   chief executive officer and executive editor,  JMIR Publications has grown to now include 35 journals that have published over 52,000 papers that have garnered over 500,000 citations and millions of views from users around the world.  

Group of 25 research funders and publishers collaborate in experimental project to unlock funding information to progress open access